Clinical Trial Update: The Effect of GCSF in the Treatment of ALS Patients [Phase 2, Phase 3]

View source ↗

Summary

The document reports the completion of a Phase 2/3 trial evaluating granulocyte colony-stimulating factor (G-CSF) for amyotrophic lateral sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• G-CSF (granulocyte colony-stimulating factor)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Amyotrophic Lateral Sclerosis | Phase 2, Phase 3 | Status: COMPLETED